Work

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

Year: 2015

Type: article

Source: European Heart Journal

DOI: 10.1093/eurheartj/ehv116

Authors: Christoph Varenhorst, Niclas Eriksson, Åsa Johansson, Bryan J. Barratt, Emil Hagström, Axel Åkerblom, Ann-Christine Syvänen, Richard C. Becker, Stefan K. James, Hugo A. Katus, Steen Husted, Ph. Gabriel Steg, Agneta Siegbahn, Deepak Voora, Renli Teng, Robert F. Storey, Lars Wallentin

Institutions: Uppsala University, Science for Life Laboratory, AstraZeneca (United Kingdom), University of Cincinnati, University of Cincinnati Medical Center, University Hospital Heidelberg, Regional Hospital West Jutland, Inserm, Sorbonne Paris Cité, Royal Brompton Hospital, Assistance Publique – Hôpitaux de Paris, Laboratoire de Recherche Vasculaire Translationnelle, Hôpital Bichat-Claude-Bernard, Université Paris Diderot, Duke Medical Center, Duke Clinical Research Institute, AstraZeneca (United States), University of Sheffield

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2162222500

FWCI: 15.14

Cites: 23

Cited by: 146

Related to: 10